Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -27.92% | -62.93% |
Feb. 20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
Feb. 08 | Syncona's Fiscal Q3 NAV Declines | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-62.93% | 0 | |
+12.07% | 3,131B | |
+11.35% | 87.46B | |
+14.31% | 84.87B | |
-6.96% | 58.67B | |
+42.75% | 54.23B | |
-18.80% | 50.1B | |
+21.19% | 42.64B | |
+32.27% | 30.36B | |
-8.72% | 25.06B |
- Stock
- Equities
- Stock Myriad Group AG - Swiss Exchange
- News Myriad Group AG
- Myriad : Syncona Unit Freeline Therapeutics Makes Changes In Clinical Development Plan for Hemophilia B Trial